Circuit Split On Cannabis Prosecutions Heightens Uncertainty
While state-legal sales of medical and recreational cannabis are projected to rise to $33 billion annually in 2022,[1] cannabis's ongoing Schedule I status under the Controlled Substances Act complicates the ability...To view the full article, register now.
Already a subscriber? Click here to view full article